Clinical and virological outcomes with baloxavir compared with oseltamivir in pediatric patients aged 6 to < 12 years with influenza: an open-label, randomized, active-controlled trial protocol

BACKGROUND: Children with influenza virus infections are prone to complications and are common sources of influenza transmission. Baloxavir marboxil inhibits cap-dependent endonuclease and was approved for influenza treatment in adolescent, adult, and pediatric patients in Japan. The miniSTONE-2 stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishiguro, Nobuhisa, Morioka, Ichiro, Nakano, Takashi, Furukawa, Masashi, Tanaka, Shintaro, Kinoshita, Masahiro, Manabe, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350309/
https://www.ncbi.nlm.nih.gov/pubmed/34372769
http://dx.doi.org/10.1186/s12879-021-06494-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350309/
https://www.ncbi.nlm.nih.gov/pubmed/34372769
http://dx.doi.org/10.1186/s12879-021-06494-w

Ejemplares similares